Welcome Cocktail Reception / Poster Session — ASN Events

Welcome Cocktail Reception / Poster Session — ASN Events

Welcome Cocktail Reception / Poster Session

VIRMA amplification drives oncogenesis and chemoresistance in High Grade Serous Ovarian Cancer (#100)

Stephanie Adler

Barriers to Exogenous RNA-mediated Gene Silencing in Phytophthora cinnamomi (#101)

Luciasih Agustini

Dory lncRNA modulates female-specific hippocampal spatial memory (#102)

A histone variant establishes a novel link between chromatin and nuclear RNA decay in spermatogenesis and beyond. (#103)

Nazmul Hasan Apu

Characterising the role of Z-DNA in the context of ADAR1 localisation and functionality in Alzheimer’s disease (#104)

Gabriel John Araneta

Functional and Epitranscriptomic Characterisation of Phage-Encoded tRNAs (#105)

Targeted RNA Capture-Seq enables splicing assessment of lowly expressed Mendelian disease genes from accessible tissues (#106)

Lipid nanoparticles enable high-efficiency CRISPR HDR-mediated gene insertions in primary human T cells (#107)

Jagan Billakanti

Freeze-Drying Improves the Stability of Unencapsulated mRNA (#108)

Hidden Genes: New Technologies for Functional Annotation of Long Noncoding RNAs in Cancer (#109)

CoZyCap^TM T7 RNA Polymerase: an enzymatic solution for efficient co-transcriptional capping (#110)

A Group I Intron Reporter Reveals a Novel RNA Quality Control Pathway in Mammalian Cells (#111)

Lachlan Bullman

Isolation of Protein Corona on mRNA Lipid Nanoparticles for Spleen-Targeted Cancer Vaccination (#112)

Investigating the regulatory roles of microRNA clusters in neuroblastoma development (#113)

Regina Belen P Callanta

A pseudo-longitudinal single-cell framework uncovers ovarian lncRNAs linked to cancer emergence and chemoresistance (#114)

Larissa Cassiano

Connecting long noncoding RNAs to drug response in high-grade serous ovarian cancer (#115)

Inhibition of KRAS by steric-blocking 2′-O-methyl phosphorothioate RNA antisense oligonucleotides (#116)

Cellulose Nanocrystals as a Biodegradable Nanoparticle Platform for siRNA Delivery and Gene Silencing in Plants (#117)

Development of a Patient-Specific Splice-Switching Antisense Oligonucleotide for SLC6A1 Neurodevelopmental Disorder (#118)

Long noncoding RNAs in the etiology of brain disorders and complex traits (#119)

Mitchell Cummins

New Zealand’s RNA Platform and the Development of Novel Ionizable Lipids (#120)

Gabriella Davey

Beyond COVID-19: Building Scalable RNA Manufacturing for Australia's Future (#121)

Can TLR2/6 stimulation Enhance mRNA vaccine Immunogenicity? (#122)

Ellie Doubleday

Mapping Tumor-Intrinsic 5'UTR Structural Vulnerabilities for Selective mRNA Therapeutics (#123)

PROFILING RNA STRUCTURAL HETEROGENEITY IN Arabidopsis thaliana (#124)

Putri Adiela Agson Gani

A Framework-Based Systematic Review for Qualifying Circulating RNA Biomarker Evidence: A Case Study in Age-Related Macular Degeneration (#125)

Tadele Gashayie

Bridging structure and function of RNA through the lens of structural modules (#126)

Uncovering New Mechanisms That Restrain Innate Sensing of Self Double-Stranded RNA (#127)

Jacki E Heraud-Farlow

A modular platform for site-specific epitranscriptomic analysis using mass spectrometry (#128)

UPF3A and UPF3B shape the transcriptome cooperatively through nonsense mediated mRNA decay yet oppose cell function (#129)

Lachlan A Jolly

Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen (#130)

Dicodon organization links tRNA modifications to cancer cell proteome (#131)

mRNA reference standards to evaluate the design, manufacture and performance of mRNA medicines. (#132)

Salina Tondwalkar

Using self-amplifying RNA to deliver antiviral gene silencing (#133)

Exploiting a Conserved Ligand-Binding Mode to Overcome cfr-Mediated Ribosomal Resistance (#134)

Multidimensional high-throughput screening and regulatory mechanism analysis of functional elements in human genome-wide mRNA 3’UTR (#135)

Functional role of m6A-RNA methylation in the regulation of neural network and memory assembly (#136)

A conserved RNA methyltransferase plays a key role in the regulation of arginine uptake by the intracellular parasite Toxoplasma gondii. (#137)

Victor V Makota

Adaptive Integration of Heterogeneous Foundation Models to Find Histologically Predictable Genes in Breast Cancer (#138)

The RNA Development Platform: Building RNA Capability in Aotearoa New Zealand (#139)

Insights into Transposable Element taming in Austropuccinia psidii (#140)

Sebastian N Orellana-Quinteros

Seed delivered dual-action RNAi for insect control and modified plant traits (#141)

Soumitra Patekar

Sustained Analgesia by Modulation of Synaptic Vesicle Endocytosis in Nociceptors Using a dCas9 Repression Strategy (#142)

Thomas J. Payne

Harnessing a Fuligo septica catalytic RNA as the basis of a molecular switch (#143)

Development and validation of a Self-Amplifying RNA platform (#144)

Development of novel circRNA liquid biopsy biomarkers for mesothelioma diagnosis (#145)

An Integrated Design–Build–Test Workflow for Computational Engineering and Functional Validation of Synthetic mRNAs (#146)

Investigating Paternal Epigenetic Inheritance via small non-coding RNA: Intergenerational effects of Paternal Immune Activation (#147)

Sonali N Reisinger

Programmable Translation Using Engineered tRNAs (#148)

Natalie K Roberts

T2G: A high-performance transcriptome-to-genome BAM coordinate converter supporting both short and long-read RNA sequencing. (#149)

Danielle L Rudler

Convergent, program-specific cis-regulation shapes the multi-layer translational response of starved yeast (#150)

Nikolay Shirokikh

Optimising mRNA Design by Rethinking UTR Structural Constraints (#151)

The Long and Short of It: Novel Transcript Discovery in Melanoma Using Nanopore Long-read RNA Sequencing (#152)

Understanding the molecular grammar of RNA interactions (#153)

Pall Thordarson

Investigating the biodistribution of morpholino oligomers in the central nervous system of mice (#154)

Vanja Todorovski

Behavioural Phenotyping of Adar1-Editing Deficient and Adar1/Adar2 Compound-Editing Deficient Mice. (#155)

Reprograming Activated Fibroblasts with Fibroblast Activation Protein-Targeted mRNA-LNPs for Cardiac Tissue Regeneration and Cancer Immunotherapy (#156)